pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
789
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
CK-0804
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
Cellenkos Inc
1
catalysts
Phase 1
EBTATE
Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)
Molecular Targeting Technologies Inc
1
catalysts
Phase 1
HLK-0006
Anaphylaxis
Pharmacin BV
1
catalysts
Phase 1
← prev
page 1 of 27
next →
131
Pain
89
Neurology
1
RP-72
Metastatic Pancreatic Cancer
Rise Biopharmaceutical Ltd
1
catalysts
Phase 1
(acetaminophen + hydrocodone bitartrate)IR
(acetaminophen + hydrocodone bitartrate)
Pain
Acura Pharmaceuticals Inc
0
catalysts
Phase 1
(amoxicillin + clavulanic acid [INN])
Otitis Media
Kaizen Bioscience Co
0
catalysts
Phase 1
(carbidopa + levodopa) CR
(carbidopa + levodopa)
Parkinson's Disease
Aromatic-L-amino-acid decarboxylase
Hong Kong WD Pharmaceutical Co Ltd
0
catalysts
Phase 1
(cefiderocol + xeruborbactam)
(cefiderocol + xeruborbactam [INN])
Gram-Negative Bacterial Infections
Qpex Biopharma Inc
0
catalysts
Phase 1
(ceftibuten + xeruborbactam)
(ceftibuten + xeruborbactam [INN])
Pyelonephritis
Qpex Biopharma Inc
0
catalysts
Phase 1
(ibudilast + bumetanide)
(ibudilast [INN] + bumetanide)
Autism Spectrum Disorder (ASD)
Stalicla SA
0
catalysts
Phase 1
(ketotifen + ibuprofen)
(ketotifen [INN] + ibuprofen)
Opium Withdrawal Syndrome
Sen-Jam Pharmaceutical Inc
0
catalysts
Phase 1
(lopinavir + ritonavir)
Lopinavir + Ritonavir ((lopinavir + ritonavir))
Cervical Intraepithelial Neoplasia (CIN)
$DARE
Dare Bioscience, Inc.
0
catalysts
Phase 1
212Pb-GRPR
Cervical Cancer
Orano Med LLC
0
catalysts
Phase 1
3D-1015
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
3D Medicines Inc
0
catalysts
Phase 1
43922
Congenital Hypoplastic Anemia
Apriligen LLC
0
catalysts
Phase 1
820 TCR
Breast Cancer
T-Cure Bioscience Inc
0
catalysts
Phase 1
8R-70CAR T cells
Glioblastoma Multiforme (GBM)
University of Florida
0
catalysts
Phase 1
AAT-009
Alzheimer's Disease
AskAt Inc
0
catalysts
Phase 1
AB-1015
Epithelial Ovarian Cancer
Arsenal Biosciences Inc
0
catalysts
Phase 1
AB-207
Muscle Atrophy
Angiocrine Bioscience Inc
0
catalysts
Phase 1
AB-598
Adenocarcinoma Of The Gastroesophageal Junction
$RCUS
Arcus Biosciences, Inc.
0
catalysts
Phase 1
ABA-101
Primary Progressive Multiple Sclerosis (PPMS)
Abata Therapeutics
0
catalysts
Phase 1
ABBV-547
Psoriasis
$ABBV
AbbVie Inc.
0
catalysts
Phase 1
ABD-147
Neuroendocrine Carcinoma
Abdera Therapeutics Inc
0
catalysts
Phase 1
ABI-1179
Genital Herpes
$GILD
GILEAD SCIENCES, INC.
0
catalysts
Phase 1
ABS-0871
Charcot-Marie-Tooth Disease Type II
Actio Biosciences Inc
0
catalysts
Phase 1
ABSK-112
Non-Small Cell Lung Cancer
Abbisko Therapeutics Co Ltd
0
catalysts
Phase 1
ABSK-121
Bile Duct Cancer (Cholangiocarcinoma)
Abbisko Therapeutics Co Ltd
0
catalysts
Phase 1
ABX-1100
Pompe Disease
Aro Biotherapeutics Co
0
catalysts
Phase 1
AC-0676
Diffuse Large B-Cell Lymphoma
Accutar Biotechnology Inc
0
catalysts
